These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 29907337)
1. Hematologic variables associated with brain failure in patients with small-cell lung cancer. Suzuki R; Wei X; Allen PK; Welsh JW; Komaki R; Lin SH Radiother Oncol; 2018 Sep; 128(3):505-512. PubMed ID: 29907337 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Suzuki R; Lin SH; Wei X; Allen PK; Welsh JW; Byers LA; Komaki R Radiother Oncol; 2018 Mar; 126(3):499-505. PubMed ID: 29398150 [TBL] [Abstract][Full Text] [Related]
3. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers. Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277 [TBL] [Abstract][Full Text] [Related]
4. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Shao N; Cai Q Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392 [TBL] [Abstract][Full Text] [Related]
5. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer? Sert F; Cosgun G; Yalman D; Ozkok S Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415 [TBL] [Abstract][Full Text] [Related]
6. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy. Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828 [TBL] [Abstract][Full Text] [Related]
7. Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging. Eze C; Roengvoraphoj O; Niyazi M; Hildebrandt G; Fietkau R; Belka C; Manapov F Clin Lung Cancer; 2017 Jul; 18(4):e243-e249. PubMed ID: 28065620 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : A retrospective study. Chen Y; Li J; Hu Y; Zhang Y; Lin Z; Zhao Z; Jiao S Strahlenther Onkol; 2016 Dec; 192(12):905-912. PubMed ID: 27605237 [TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy. Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661 [TBL] [Abstract][Full Text] [Related]
10. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease? Gong L; Wang QI; Zhao L; Yuan Z; Li R; Wang P Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):196-200. PubMed ID: 22818415 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647 [TBL] [Abstract][Full Text] [Related]
14. Risk stratification of symptomatic brain metastases by clinical and FDG PET parameters for selective use of prophylactic cranial irradiation in patients with extensive disease of small cell lung cancer. Chung JH; Kang SY; Wu HG; Seo YS; Kim DW; Kang KW; Kim HJ; Cheon GJ Radiother Oncol; 2020 Feb; 143():81-87. PubMed ID: 32044172 [TBL] [Abstract][Full Text] [Related]
15. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients. Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525 [TBL] [Abstract][Full Text] [Related]
17. Correlation between stage of small-cell lung cancer and inflammatory factors. Kim T; Choi H; Oak CH; Jang TW; Jung MH; Kim J Asian Cardiovasc Thorac Ann; 2019 Sep; 27(7):554-558. PubMed ID: 31379186 [No Abstract] [Full Text] [Related]
18. Effect of Pretreatment Platelet Parameters on Survival in Limited Disease Small Cell Lung Cancer. Sakin A; Yasar N; Arici S; Demir C; Geredeli C; Aksaray F; Isik S; Cihan S Asian Pac J Cancer Prev; 2019 Jun; 20(6):1879-1885. PubMed ID: 31244313 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation. Ji Z; Bi N; Wang J; Hui Z; Xiao Z; Feng Q; Zhou Z; Chen D; Lv J; Liang J; Fan C; Liu L; Wang L Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):330-7. PubMed ID: 24725335 [TBL] [Abstract][Full Text] [Related]
20. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer. Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]